Amgen, Inc. (AMGN)
377.20
-0.15
(-0.04%)
USD |
NASDAQ |
Sep 14, 10:17
Amgen Total Return Level : 565.06 for Sept. 11, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 11, 2026 | 565.06 |
| September 10, 2026 | 572.72 |
| September 09, 2026 | 585.90 |
| September 08, 2026 | 588.74 |
| September 04, 2026 | 654.72 |
| September 03, 2026 | 665.04 |
| September 02, 2026 | 663.12 |
| September 01, 2026 | 656.05 |
| August 31, 2026 | 643.72 |
| August 28, 2026 | 647.52 |
| August 27, 2026 | 654.36 |
| August 26, 2026 | 659.38 |
| August 25, 2026 | 662.22 |
| August 24, 2026 | 664.62 |
| August 21, 2026 | 657.87 |
| August 20, 2026 | 645.78 |
| August 19, 2026 | 658.63 |
| August 18, 2026 | 633.20 |
| August 17, 2026 | 624.41 |
| August 14, 2026 | 618.20 |
| August 13, 2026 | 622.12 |
| August 12, 2026 | 619.65 |
| August 11, 2026 | 616.85 |
| August 10, 2026 | 621.17 |
| August 07, 2026 | 611.85 |
| Date | Value |
|---|---|
| August 06, 2026 | 602.78 |
| August 05, 2026 | 607.21 |
| August 04, 2026 | 580.70 |
| August 03, 2026 | 564.10 |
| July 31, 2026 | 573.46 |
| July 30, 2026 | 577.15 |
| July 29, 2026 | 577.15 |
| July 28, 2026 | 585.28 |
| July 27, 2026 | 560.21 |
| July 24, 2026 | 559.88 |
| July 23, 2026 | 553.12 |
| July 22, 2026 | 545.01 |
| July 21, 2026 | 545.29 |
| July 20, 2026 | 542.21 |
| July 17, 2026 | 545.37 |
| July 16, 2026 | 553.24 |
| July 15, 2026 | 533.50 |
| July 14, 2026 | 528.93 |
| July 13, 2026 | 536.67 |
| July 10, 2026 | 541.05 |
| July 09, 2026 | 541.39 |
| July 08, 2026 | 547.90 |
| July 07, 2026 | 548.06 |
| July 06, 2026 | 545.59 |
| July 02, 2026 | 557.07 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 209.46 |
| Regeneron Pharmaceuticals, Inc. | 788.74 |
| AbbVie, Inc. | 442.89 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
| Biogen, Inc. | 217.15 |